ArticleIranian journal of public health2018

Cost-effectiveness of Oral Protease Inhibitors Co-administration versus Pegylated Interferon-Α2b and Ribavirin Only for the Patients with Hepatitis C Genotype 1 in Kazakhstan Health Care Settings.

Alima Almadiyeva et al.PubMed ↗Full text ↗

No numbers read from the abstract.